C21 Investments Inc (CXXIF)
0.243
0.00 (0.00%)
USD |
OTCM |
Sep 20, 09:43
C21 Investments Total Liabilities (Quarterly): 27.36M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 27.36M |
January 31, 2024 | 23.48M |
October 31, 2023 | 21.93M |
July 31, 2023 | 22.45M |
April 30, 2023 | 22.76M |
January 31, 2023 | 24.00M |
October 31, 2022 | 23.61M |
July 31, 2022 | 24.62M |
April 30, 2022 | 26.18M |
January 31, 2022 | 28.12M |
October 31, 2021 | 28.81M |
July 31, 2021 | 33.03M |
April 30, 2021 | 38.22M |
January 31, 2021 | 43.56M |
October 31, 2020 | 42.57M |
July 31, 2020 | 45.54M |
April 30, 2020 | 45.34M |
January 31, 2020 | 47.87M |
October 31, 2019 | 57.58M |
July 31, 2019 | 59.25M |
April 30, 2019 | 59.62M |
January 31, 2019 | 56.35M |
October 31, 2018 | 6.397M |
July 31, 2018 | 7.518M |
April 30, 2018 | 0.6519M |
Date | Value |
---|---|
January 31, 2018 | 0.2094M |
October 31, 2017 | 0.1026M |
July 31, 2017 | 0.0986M |
April 30, 2017 | 0.3985M |
January 31, 2017 | 0.4053M |
October 31, 2016 | 0.3806M |
July 31, 2016 | 0.3774M |
April 30, 2016 | 0.3763M |
January 31, 2016 | 0.3273M |
October 31, 2015 | 0.3362M |
July 31, 2015 | 0.3265M |
April 30, 2015 | 0.3205M |
January 31, 2015 | 0.2882M |
October 31, 2014 | 0.32M |
July 31, 2014 | 0.3098M |
April 30, 2014 | 0.2679M |
January 31, 2014 | 0.2473M |
October 31, 2013 | 0.1429M |
July 31, 2013 | 0.1038M |
April 30, 2013 | 0.0762M |
January 31, 2013 | 0.1196M |
October 31, 2012 | 0.1223M |
July 31, 2012 | 0.0961M |
April 30, 2012 | 0.0608M |
January 31, 2012 | 0.1068M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
21.93M
Minimum
Oct 2023
57.58M
Maximum
Oct 2019
33.00M
Average
28.12M
Median
Jan 2022
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 10.35M |
Aurinia Pharmaceuticals Inc | 158.91M |
Edesa Biotech Inc | 2.361M |
Lexaria Bioscience Corp | 0.2714M |
Xenon Pharmaceuticals Inc | 39.96M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 58.32M |
Shareholders Equity (Quarterly) | 30.96M |
Debt to Equity Ratio | 0.1032 |
Current Ratio | 0.4967 |
Net Debt Paydown Yield | -0.01% |